-
公开(公告)号:EP1229908A1
公开(公告)日:2002-08-14
申请号:EP00980405.5
申请日:2000-11-15
申请人: ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. , Marshall, Mark Steven , Sweeney, Christopher J. , Yip-Schneider, Michelle T. , Crowell, Pamela L.
发明人: MARSHALL, Mark, Steven , SWEENEY, Christopher J. , YIP-SCHNEIDER, Michelle, T. , CROWELL, Pamela, L.
IPC分类号: A61K31/19 , A61K31/405 , A61P35/00
CPC分类号: A61K45/06 , A61K31/00 , A61K31/192 , A61K31/405 , A61K31/4965 , A61K31/7068 , A61K2300/00
摘要: The invention provides a method comprising the use of non-steroidal antiinflammatory drugs (NSAIDs), particularly sulindac or its analogs to treat pancreatic cancer.
-
公开(公告)号:EP1227846A2
公开(公告)日:2002-08-07
申请号:EP00975626.3
申请日:2000-11-10
申请人: ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. , Clapp, Wade D. , Ingram, David A. , Marshall, Mark Steven
IPC分类号: A61K45/00
CPC分类号: G01N33/6896 , A61K31/00 , A61K31/352 , A61K31/5377 , G01N2333/4703 , G01N2500/10
摘要: A method is provided to identify inhibitors of any one of Raf, MEK, extracellular signal regulated kinase 1 (ERK1), extracellular signal regulated kinase 2 (ERK2), phosphatidylinositol triphosphate kinase (PI3K), p21 activated kinase 2 (PAK2), p21 activated kinase 3 (PAK3), Rac, CDC42, p21 activated kinase 1 (PAK1), protein kinase B (PKB), Akt, and c-jun N-terminal kinase (JNK), or crosstalk between the PI3-K an the Ras-Raf-MEK-ERK pathway, useful to treat disorders such as neurofibromatosis type 1 or at least one clinical manifestation thereof.
-